Gyeong‐Won Lee

Learn More
BACKGROUND Sarcopenia is known to be related to an increased risk of chemotherapy toxicity and to a poor prognosis in patients with malignancy. We assessed the prognostic role of sarcopenia in patients with diffuse large B-cell lymphoma (DLBCL). METHODS In total, 187 consecutive patients with DLBCL treated with induction rituximab, cyclophosphamide,(More)
  • 1